Our mission is to deliver solutions and bring hope to as many people as possible.
Biosimilar medicines enable us to do so, by ensuring access to treatments and contributing to the sustainability of healthcare systems worldwide.
More info
mAbxience is a Spanish fully-fledged biotech company with a decade of experience in developing and manufacturing biosimilars.
Part of the Spanish multinational Insud Pharma (formerly Chemo), a group with +40 years of experience, more than 6,000 professionals and presence in 40 countries around the world.
CPhI & BIO-EUROPE 2019
Meet us at CPhl, to be held 5-7 November in Frankfurt, Germany. Meet us at BIO-EUROPE, to be held 11-13 November in Hamburg, Germany.
+
Our business model is B2B (business to business), with global partnership network of key market leaders in the EU, US, Japan and emerging markets.
+